Clinical Trial Update: Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy, safety, and pharmacokinetics of Virchow IVIG in patients with primary immunodeficiency diseases, currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Diseases

Drugs mentioned

• Virchow IVIG (intravenous immunoglobulin)

Snippet

Sponsor: Virchow Group | Conditions: Primary Immunodeficiency Diseases (PID) | Phase 3 | Status: NOT_YET_RECRUITING